Proactive Investors - Run By Investors For Investors

Arcadia Biosciences nears commercialization of its new wheat-based products

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar and CFO Matt Plavan tells Proactive Investors the health and nutrition company is getting very close to commercialization of its technology to produce new, healthier wheat products with consumer packaged-goods companies using both enriched and whole wheat RS wheat flour.

Ketkar says the California-based company's products, including a form of resistant starch, manage obesity and diabetes since the body takes longer to break down starch in the wheat, allowing consumers to feel more full. Plavan adds the company is well funded, recently closing on $13.83mln worth of capital.

 
Meet ICOx Innovations at our event, New York , 30 January 2019. Register here »
View full RKDA profile View Profile

Arcadia Biosciences Inc Timeline

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use